Journal of Clinical Oncology, Vol 10, 1674-1681, Copyright © 1992 by American Society of Clinical Oncology

ARTICLES

Breast cancer in patients irradiated for Hodgkin's disease: a clinical and pathologic analysis of 45 events in 37 patients

J Yahalom, JA Petrek, PW Biddinger, S Kessler, DD Dershaw, B McCormick, MP Osborne, DA Kinne and PP Rosen
Department of Radiation Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY 10021.

PURPOSE: To characterize the clinical and pathologic features of patients who developed breast cancer (BC) after treatment for Hodgkin's disease (HD). Recent epidemiologic studies have shown that women who are cured of HD have an increased risk of developing BC. PATIENTS AND METHODS: The clinical data, mammograms, and pathologic specimens of 37 women who developed 45 BCs (eight bilateral events), and had a prior history of treatment for HD were analyzed. RESULTS: The median age at diagnosis of HD was 27 years (range, 11 to 60). All patients received radiotherapy (RT) to the upper part of their body, and 10 also had chemotherapy for HD. The median interval from the treatment of HD to the diagnosis of BC was 15 years (range, 8 to 34). The median age at diagnosis of BC was 43 years (range, 27 to 75), 41% of patients were 39 years old or younger. Most mammograms (81%) showed abnormal findings of mass and/or microcalcifications. Of the eight patients (22%) with bilateral tumors, four were synchronous and four were metachronous. Involvement of the medial half of the breast occurred more frequently than in patients with primary BC (39% and 21%, respectively; P < .002). But, the histologic types, grades, presence of lymphocytic reaction, and lymphatic invasion were similar to those observed in 935 primary BC patients who were previously analyzed at our center. The 6-year actuarial relapse-free survival (RFS) for node-negative BC after HD was 85%. Node-positive patients had a significantly lower RFS of 33% (P = .002). CONCLUSIONS: In comparison to patients with primary BC, patients who develop BC after HD are more likely to be younger, have bilateral disease, and have their tumors more frequently involve the medial half of the breast. Pathologic characteristics, nodal involvement, and prognosis are similar to those of primary BC. BC in women who were treated for HD is becoming an increasing problem, as more patients cured of HD reach a follow-up time of 10 to 15 years. Breast examination and mammography at an early age should be part of the follow-up program for women who are cured of HD.

This article has been cited by other articles:

				L. Lee, M. Pintilie, D. C. Hodgson, P. E. Goss, and M. Crump Screening mammography for young women treated with supradiaphragmatic radiation for Hodgkin's lymphoma Ann. Onc., January 1, 2008; 19(1): 62 - 67. [Abstract] [Full Text] [PDF]

				A. M. Allen and R. B. Tishler Commentary: IMRT for Head and Neck Cancer: Many Chapters Left to Write Oncologist, May 1, 2007; 12(5): 565 - 568. [Abstract] [Full Text] [PDF]

				E. M. Noordijk, P. Carde, N. Dupouy, A. Hagenbeek, A. D.G. Krol, J. C. Kluin-Nelemans, U. Tirelli, M. Monconduit, J. Thomas, H. Eghbali, et al. Combined-Modality Therapy for Clinical Stage I or II Hodgkin's Lymphoma: Long-Term Results of the European Organisation for Research and Treatment of Cancer H7 Randomized Controlled Trials J. Clin. Oncol., July 1, 2006; 24(19): 3128 - 3135. [Abstract] [Full Text] [PDF]

				L. B. Kenney, Y. Yasui, P. D. Inskip, S. Hammond, J. P. Neglia, A. C. Mertens, A. T. Meadows, D. Friedman, L. L. Robison, and L. Diller Breast Cancer after Childhood Cancer: A Report from the Childhood Cancer Survivor Study Ann Intern Med, October 19, 2004; 141(8): 590 - 597. [Abstract] [Full Text] [PDF]

				K. Behringer, A. Josting, P. Schiller, H. T. Eich, H. Bredenfeld, V. Diehl, and A. Engert Solid tumors in patients treated for Hodgkin's disease: a report from the German Hodgkin Lymphoma Study Group Ann. Onc., July 1, 2004; 15(7): 1079 - 1085. [Abstract] [Full Text] [PDF]

				K. C. Oeffinger and M. M. Hudson Long-term Complications Following Childhood and Adolescent Cancer: Foundations for Providing Risk-based Health Care for Survivors CA Cancer J Clin, July 1, 2004; 54(4): 208 - 236. [Abstract] [Full Text] [PDF]

				A. K. Ng, S. Li, D. Neuberg, B. Silver, J. Weeks, and P. Mauch Factors influencing treatment recommendations in early-stage Hodgkin's disease: a survey of physicians Ann. Onc., February 1, 2004; 15(2): 261 - 269. [Abstract] [Full Text] [PDF]

				S. Bhatia, Y. Yasui, L. L. Robison, J. M. Birch, M. K. Bogue, L. Diller, C. DeLaat, F. Fossati-Bellani, E. Morgan, O. Oberlin, et al. High Risk of Subsequent Neoplasms Continues With Extended Follow-Up of Childhood Hodgkin's Disease: Report From the Late Effects Study Group J. Clin. Oncol., December 1, 2003; 21(23): 4386 - 4394. [Abstract] [Full Text] [PDF]

				L. B. Travis, D. A. Hill, G. M. Dores, M. Gospodarowicz, F. E. van Leeuwen, E. Holowaty, B. Glimelius, M. Andersson, T. Wiklund, C. F. Lynch, et al. Breast Cancer Following Radiotherapy and Chemotherapy Among Young Women With Hodgkin Disease JAMA, July 23, 2003; 290(4): 465 - 475. [Abstract] [Full Text] [PDF]

				J. Yahalom Breast Cancer After Hodgkin Disease: Hope for a Safer Cure JAMA, July 23, 2003; 290(4): 529 - 531. [Full Text] [PDF]

				F. E. van Leeuwen, W. J. Klokman, M. Stovall, E. C. Dahler, M. B. van't Veer, E. M. Noordijk, M. A. Crommelin, B. M. P. Aleman, A. Broeks, M. Gospodarowicz, et al. Roles of Radiation Dose, Chemotherapy, and Hormonal Factors in Breast Cancer Following Hodgkin's Disease J Natl Cancer Inst, July 2, 2003; 95(13): 971 - 980. [Abstract] [Full Text] [PDF]

				K. Offit, S. Gilad, S. Paglin, P. Kolachana, L. C. Roisman, K. Nafa, V. Yeugelewitz, M. Gonzales, M. Robson, D. McDermott, et al. Rare Variants of ATM and Risk for Hodgkin's Disease and Radiation-associated Breast Cancers Clin. Cancer Res., December 1, 2002; 8(12): 3813 - 3819. [Abstract] [Full Text] [PDF]

				A. K. Ng, M. V. P. Bernardo, E. Weller, K. Backstrand, B. Silver, K. C. Marcus, N. J. Tarbell, M. A. Stevenson, J. W. Friedberg, and P. M. Mauch Second malignancy after Hodgkin disease treated with radiation therapy with or without chemotherapy: long-term risks and risk factors Blood, August 28, 2002; 100(6): 1989 - 1996. [Abstract] [Full Text] [PDF]

				L. Diller, C. M. Nancarrow, K. Shaffer, U. Matulonis, P. Mauch, D. Neuberg, N. J. Tarbell, H. Litman, and J. Garber Breast Cancer Screening in Women Previously Treated for Hodgkin's Disease: A Prospective Cohort Study J. Clin. Oncol., April 15, 2002; 20(8): 2085 - 2091. [Abstract] [Full Text] [PDF]

				K. van Besien, M. Kelta, and P. Bahaguna Primary Mediastinal B-Cell Lymphoma: A Review of Pathology and Management J. Clin. Oncol., March 15, 2001; 19(6): 1855 - 1864. [Abstract] [Full Text] [PDF]

				C. Behrens, L. B. Travis, I. I. Wistuba, S. Davis, A. Maitra, E. A. Clarke, C. F. Lynch, B. Glimelius, T. Wiklund, R. Tarone, et al. Molecular Changes in Second Primary Lung and Breast Cancers after Therapy for Hodgkin's Disease Cancer Epidemiol. Biomarkers Prev., October 1, 2000; 9(10): 1027 - 1035. [Abstract] [Full Text]

				D. C. Linch, R. G. Gosden, T. Tulandi, S.-L. Tan, and S. L. Hancock Hodgkin's Lymphoma: Choice of Therapy and Late Complications Hematology, January 1, 2000; 2000(1): 205 - 221. [Abstract] [Full Text] [PDF]

				B. Mesurolle, S. D. Qanadli, M. Merad, F. Mignon, P. Baldeyrou, A. Tardivon, P. Lacombe, and D. Vanel Unusual Radiologic Findings in the Thorax after Radiation Therapy RadioGraphics, January 1, 2000; 20(1): 67 - 81. [Abstract] [Full Text] [PDF]

				A. K. Ng, J. C. Weeks, P. M. Mauch, and K. M. Kuntz Decision Analysis on Alternative Treatment Strategies for Favorable-Prognosis, Early-Stage Hodgkin's Disease J. Clin. Oncol., November 1, 1999; 17(11): 3577 - 3585. [Abstract] [Full Text] [PDF]

				K. E. Nichols, S. Levitz, K. E. Shannon, D. C.R. Wahrer, D. W. Bell, G. Chang, S. Hegde, D. Neuberg, T. Shafman, N. J. Tarbell, et al. Heterozygous Germline ATM Mutations Do Not Contribute to Radiation-Associated Malignancies After Hodgkin's Disease J. Clin. Oncol., April 1, 1999; 17(4): 1259 - 1259. [Abstract] [Full Text] [PDF]